E. GERALD KAY - 06 May 2022 Form 4/A - Amendment Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role
Executive Chairman & President, Director, 10%+ Owner
Signature
/s/ E. Gerald Kay
Issuer symbol
INBP
Transactions as of
06 May 2022
Net transactions value
+$23,000
Form type
4/A - Amendment
Filing time
11 May 2022, 14:37:26 UTC
Date Of Original Report
06 May 2022
Previous filing
04 Nov 2021
Next filing
10 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INBP Common Stock Options Exercise $23,000 +100,000 +1.9% $0.2300 5,345,889 06 May 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (right to buy) Options Exercise $0 -100,000 -40% $0.000000 150,000 06 May 2022 Common Stock 100,000 $0.2300 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being amended to correct the Transaction Code in Table 1 and to include the previously inadvertently omitted disclosure in Table II.
F2 100,000 common stock shares acquired upon exercise of stock option grant dated May 24, 2019.
F3 The option vested 50% (125,000) on grant date (May 24, 2019) and in three equal annual installments for the remaining 50% (125,000) beginning on May 24, 2020 and ending May 24, 2022.